1[13]Ko CM,Ducic I, Fan J, et al. Suppression of mammalian K + channelfamily by ebastine[J]. Pharmacol Exp Ther, 1997,281:233~244
2[14]Ducic I,Ko CM,Shuba Y,et al. Comparative effects of loratadine and terfenadine on cardiac K + channels [J]. J Cardiovasc Pharmacol,1997,30:42~54
3[15]Suessbrich H,Waldegger S, Lang F, et al. Blockade of HERC channels expressed in xenopus oocytes by the histamine recepter antagonists terfenadine and astemixole[J]. FEBS, 1996,385: 77~80
4[16]Paserchia LA, Hewett J, Woosley RL, et al. Effect of ketoconazlole on QTc[J]. Clin Pharmacol Ther, 1994,55: 146
5[17]Biton B, Maitre S, Godet D, et al. Effect of the noval nonsedating histamine H1 recepter antagonist mizolastine on cardiac potassium and sodium currents[J]. Allergy, 1998,53: 419
6[18]Leeson GA, Chan KY, Knapp WC, et al. Metabolic disposition of terfenadine in laboratory animals [J]. Arzeimittelforschung, 1982, 32:1173~1178
7[19]Michiels M, Van Peer A, Woestenborghs R, et al. Pharmcokineticsand tissue distribution of astemizole in the dog[J ]. Drug Dev Res,1986,8:53~62
8[1]Pratt CM, Ruberg S, Morganroth J, et al.Dose- response relation between terfenadine(Seldene) and QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability [J]. Am Heart J, 1996,131:472~480
9[2]Honig PK, Worthan DC, Zamani K, et al.Terfendine - ketoconazxole interaction [J].JAMA, 1993,269:1513~1518
10[3]Sale ME, Barbey JT, Woosley RL, et al.The electrocardiographic effects of cetirizine in normal subjects[J]. Clin Pharmacol Ther, 1994,54:295~301